29 June 2022 : Clinical Research
Diffusion Tensor Imaging Evaluates Effects of Acupoint Injection at Zusanli (ST36) for Type 2 Diabetic Peripheral Neuropathy
Yangkui ZhaiCEG, Wenjuan YuACE, Wen ShenE, Yan ZhangEDOI: 10.12659/MSM.935979
Med Sci Monit 2022; 28:e935979
Table 1 Demographic and baseline characteristics.
| Group | Acupoint injection | Intramuscular injection | P value |
|---|---|---|---|
| Age (years) | 49.22±5.24 | 51.58±5.66 | 0.13 |
| Male, n (%) | 49% | 38% | 0.14 |
| BMI index (kg/m) | 23.17±3.19 | 24.41±2.69 | 1.01 |
| FBG (mmol/L) | 7.81±2.11 | 8.24±2.14 | 0.63 |
| Hb (%) | 8.12±2.22 | 8.54±2.41 | 0.52 |
| Case of DR | 8 (20) | 10 (20) | 0.46 |
| UACR (mg/g) | 16.1±2.15 | 14.4±2.88 | 0.21 |
| BMI – body max index; FBG – fasting blood glucose; Hb – glycated hemoglobin; DR – diabetic retinopathy; UACR – urine albumin-creatine ratio. | |||